Skip to content

Gain Therapeutics, Inc.

GANX· Nasdaqxbrl foundCIK 1819411

Pharmaceutical preparations552 peers

Last sale
Nov 12, 2026 · -0.92%
Market cap
$48.09M
44.53M shares
Filings
243
$55.18K
FY 2023−58.4% FY23 yoy
-$3.16M
Q3 2026N/M FY25 yoy
-$3.20M
Q3 2026N/M FY25 yoy
-$18.90M
FY 2024derivedN/M FY24 yoy
-$0.07
Q3 2026N/M FY25 yoy
$11.70M
Q3 2026+100.6% FY25 yoy
$48.09M
—
—
4.7×
—
—

FY2025 figures · derived

Price

$1.0859.70%$1.60past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of record

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$55.18KFY 2023
$133.93K0FY 2020FY 2021FY 2022FY 2023
PeriodEndedValueKindSource trail
FY 20232023-12-31$55,180reported
FY 20222022-12-31$132,640reported
FY 20212021-12-31$133,928reported
FY 20202020-12-31$28,881reported

Segments

Geography
Long-lived assets by Geography, FY2023 to FY2025FY2023Switzerland · FY2023 · $445.51KSpain · FY2023 · $274.86KUnited States · FY2023 · $58.19KFY2024Switzerland · FY2024 · $282.19KSpain · FY2024 · $164.85KUnited States · FY2024 · $10.57KFY2025Switzerland · FY2025 · $253.21KSpain · FY2025 · $252.33KUnited States · FY2025 · $6.30K
LineFY2025ShareChange
Switzerland$253.21K49%−10.3%
Spain$252.33K49%+53.1%
United States$6.30K1.2%−40.4%
Total$511.84K

From the 10-K filed Mar 26, 2026GANX

Pharmaceutical preparations

Gain Therapeutics, Inc. is the 336th largest of the 553 covered companies the SEC files under this code, by market cap. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Gain Therapeutics, Inc. · CIK 1819411 · Engraved from SEC EDGAR